Skip to content

Effect of single-dose dexmedetomidine and non-sedation on postoperative cognitive dysfunction in elderly patients undergoing hip and knee surgery : a randomized controlled trial

Effect of single-dose dexmedetomidine and non-sedation on postoperative cognitive dysfunction in elderly patients undergoing hip and knee surgery : a randomized controlled trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260604002
Enrollment
120
Registered
2026-06-04
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Cognitive Dysfunction Postoperative Delirium Cognitive Impairment Elderly Surgical Patients Dexmedetomidine Postoperative Cognitive Dysfunction POCD Postoperative Delirium Cognitive Function Montreal Cognitive Assessment MMSE Spinal Anesthesia Hip Surgery Knee Surgery Elderly Patients Orthopedic Surgery Sedation Perioperative Care

Interventions

Participants receive intravenous dexmedetomidine at a dose of 0.3 to 0.5 mcg/kg administered over 10 minutes during surgery under spinal anesthesia. Standard perioperative care is provided according t
Experimental Drug,No Intervention No treatment
Single-dose Dexmedetomidine,No Sedation Control

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients aged 60 years or older. 2. Scheduled for hip or knee surgery under spinal anesthesia. 3. American Society of Anesthesiologists (ASA) physical status 2-3

Exclusion criteria

Exclusion criteria: 1. Known allergy or hypersensitivity to dexmedetomidine. 2. Contraindication to spinal anesthesia. 3. Previous exposure to general anesthesia or regional anesthesia within the preceding 12 months. 4. Conversion from spinal anesthesia to general anesthesia during surgery. 5. History of neurological disorders including stroke, epilepsy, Parkinson disease, delirium, or dementia. 6. Severe hepatic dysfunction classified as Child-Pugh class C. 7. End-stage renal disease requiring renal replacement therapy.

Design outcomes

Primary

MeasureTime frame
Postoperative Cognitive Dysfunction 72 hours, 2 weeks and 3 months after surgery Incidence of postoperative cognitive dysfunction assessed using Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE)

Secondary

MeasureTime frame
MoCA Score 72 hours, 2 weeks and 3 months after surgery Montreal Cognitive Assessment,MMSE Score 72 hours, 2 weeks and 3 months after surgery Mini-Mental State Examination,Postoperative Delirium 24 hours and 72 hours after surgery Thai version of the Confusion Assessment Method,Intraoperative Complications During surgery Occurrence of hypotension, bradycardia, and hypoxemia

Countries

Thailand

Contacts

Public ContactChonlawan Chumjang

samutsakhon hospital

c.chonlawan@hotmail.com0863484380

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026